A substituted sulfonamide and its Co (II), Cu (II), and Zn (II) complexes as potential antifungal agents

References

• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–81.
   PubMed Web of Science ®Google Scholar
• Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 2011;10:767–77.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A, Conway J, editors. Carbonic anhydrase—its Inhibitors and activators. Boca Raton (FL), New York, London: CRC Press; 2004:1–363
   Google Scholar
• Temperini C, Cecchi A, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited-old leads for new applications? Org Biomol Chem 2008;6:2499–506.
   PubMed Web of Science ®Google Scholar
• Pastorekova S, Parkkila S, Pastorek J, Supuran CT. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J Enzyme Inhib Med Chem 2004;19:199–229.
   PubMed Web of Science ®Google Scholar
• Supuran C.T., Scozzafava A., Casini A. Development of sulfonamide carbonic anhydrase inhibitors. In: Supuran CT, Scozzafava A, Conway J, editors. Carbonic anhydrase—its inhibitors and activators. Boca Raton (FL): CRC Press; 2004:67–147
   Google Scholar
• Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;27:759–72.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases: from biomedical applications of the inhibitors and activators to biotechnological use for CO(2) capture. J Enzyme Inhib Med Chem 2013;28:229–30.
   PubMed Web of Science ®Google Scholar
• Nishimori I, Onishi S, Takeuchi H, Supuran CT. The alpha and beta classes carbonic anhydrases from Helicobacter pylori as novel drug targets . Curr Pharm Des 2008;14:622–30.
   PubMed Web of Science ®Google Scholar
• Casini A, Antel J, Abbate F, et al Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV. Bioorg Med Chem Lett 2003;13:841–5.
   PubMed Web of Science ®Google Scholar
• De Simone G, Di Fiore A, Menchise V, et al Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies. Bioorg Med Chem Lett 2005;15:2315–20.
   PubMed Web of Science ®Google Scholar
• Winum JY, Dogne JM, Casini A, et al Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with N-hydroxysulfamides – a new zinc-binding function in the design of inhibitors. J Med Chem 2005;48:2121–5.
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Passaponti M, Supuran CT, Gulcin I. Carbonic anhydrase inhibitors: guaiacol and catechol derivatives effectively inhibit certain human carbonic anhydrase isoenzymes (hCA I, II, IX and XII). J Enzyme Inhib Med Chem 2015;30:586–91.
   PubMed Web of Science ®Google Scholar
• Winum JY, Pastorekova S, Jakubickova L, et al Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates. Bioorg Med Chem Lett 2005;15:579–84.
   PubMed Web of Science ®Google Scholar
• Cecchi A, Hulikova A, Pastorek J, et al Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors. J Med Chem 2005;48:4834–41.
   PubMed Web of Science ®Google Scholar
• De Simone G, Alterio V, Supuran CT. Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors. Expert Opin Drug Discov 2013;8:793–810.
   PubMed Web of Science ®Google Scholar
• Brown GD, Denning DW, Gow NA, et al Hidden killers: human fungal infections. Sci Transl Med 2012;4:165rv113
   Web of Science ®Google Scholar
• Fera MT, La Camera E, De Sarro A. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance. Expert Rev anti Infect Ther 2009;7:981–98.
   PubMed Web of Science ®Google Scholar
• Wilke M. Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin and its impact on use and costs: review of the literature. Eur J Med Res 2011;16:180–6.
   PubMed Web of Science ®Google Scholar
• Ramos PD, Moromi NH, Martínez E, Cadillo E. Porphyromonas gingivalis: predominant pathogen in chronic periodontitis. Odontol. Sanmarquina 2011;14:34–8.
   Google Scholar
• Vullo D, Del Prete S, Osman SM, et al Sulfonamide inhibition studies of the γ-carbonic anhydrase from the oral pathogen Porphyromonas gingivalis. Bioorg Med Chem Lett 2014;24:240–4.
   PubMed Web of Science ®Google Scholar
• Camí GE, Ramírez de Arellano MC, Fustero S, Pedregosa JC. Synthesis, growth and characterization of new 1,3,4-thiadiazole-5-(N-substituted)-sulfonamides crystals. J Arg Chem Soc 2006;94:5–17.
   Google Scholar
• CrysAlisPro, Oxford Diffraction Ltd., Version 1.171.36.20 (release 27-06-2012 CrysAlis171.NET)
   Google Scholar
• Sheldrick GM. A short history of SHELX. Acta Crystallogr 2008;A64:112–22.
   Web of Science ®Google Scholar
• Farrugia LJ. WinGX suite for small-molecule single-crystal crystallography. J Appl Crystallogr 1999;32:837–8.
   Web of Science ®Google Scholar
• Spek AL. Single-crystal structure validation with the program PLATON. J Appl Crystallogr 2003;36:7–13.
   Web of Science ®Google Scholar
• Macrae CF, Edgington PR, McCabe P, et al Mercury: visualization and analysis of crystal structures. J Appl Crystallogr 2006;39:453–7.
   Web of Science ®Google Scholar
• Becke AD. Density-functional exchange-energy approximation with correct asymptotic behavior. Phys Rev a Gen Phys 1988;38:3098–100.
   PubMedGoogle Scholar
• Lee C, Yang W, Parr RG. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B Condens Matter 1988;37:785–9.
   PubMed Web of Science ®Google Scholar
• Vosko SH, Wilk L, Nusair M. Accurate spin-dependent electron liquid correlation energies for local spin density calculations: a critical analysis. Can J Phys 1980;58:1200–11.
   Web of Science ®Google Scholar
• Frisch MJ, Trucks GW, Schlegel HB, et al Gaussian 09, Revision D.01. Wallingford (CT): Gaussian, Inc.; 2013
   Google Scholar
• Bader RFW. Atoms in molecules: a quantum theory. Oxford: Clarendon Press; 1990
   Google Scholar
• Bader RFW. A quantum theory of molecular structure and its applications. Chem Rev 1991;91:893–928.
   Web of Science ®Google Scholar
• Bianchi R, Gervasio G, Marabello D. Experimental electron density analysis of Mn2(CO)10: metal-metal and metal-ligand bond characterization. Inorg Chem 2000;39:2360–6.
   PubMed Web of Science ®Google Scholar
• Bader RFW. 1995. Available from: http://www.chemistry.mcmaster.ca/aimpac/imagemap/imagemap.htm.
   Google Scholar
• Biegler-Konig FW, Nguyen-Dang TT, Tal Y, et al Calculation of the average properties of atoms in molecules. J Phys B 1981;14:2739–51.
   Web of Science ®Google Scholar
• Biegler-Konig FW, Bader RFW, Tang T-H. Calculation of the average properties of atoms in molecules. II. J Comput Chem 1982;13:317–28.
   Web of Science ®Google Scholar
• Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971;246:2561–73.
   PubMed Web of Science ®Google Scholar
• Maresca A, Temperini C, Vu H, et al Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. J Am Chem Soc 2009;131:3057–62.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2010;20:3467–74.
   PubMed Web of Science ®Google Scholar
• Alafeefy AM, Ceruso M, Al-Jaber NA, et al. A new class of quinazoline-sulfonamides acting as efficient inhibitors against the α-carbonic anhydrase from Trypanosoma cruzi. J Enzyme Inhib Med Chem 2015;30:581–5.
   PubMed Web of Science ®Google Scholar
• Carta F, Di Cesare Mannelli L, Pinard M, et al A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects. Bioorg Med Chem 2015;23:1828–40.
   PubMed Web of Science ®Google Scholar
• GraphPad Prism, Graphpad Software Inc., Copyright 1994–2000 v 3.02. Available from: http://www.graphpad.com/scientific-software/prism/.
   Google Scholar
• Carta F, Aggarwal M, Maresca A, et al Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations. Chem Commun 2012;48:1868–70.
   PubMed Web of Science ®Google Scholar
• Innocenti A, Vullo D, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV). Bioorg Med Chem Lett 2008;18:1583–7.
   PubMed Web of Science ®Google Scholar
• Innocenti A, Vullo D, Scozzafava A, et al Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with carboxylates. Bioorg Med Chem Lett 2005;15:573–8.
   PubMed Web of Science ®Google Scholar
• Di Fiore A, Monti SM, Hilvo M, et al Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide. Proteins 2009;74:164–75.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibition/activation: trip of a scientist around the world in the search of novel chemotypes and drug targets. Curr Pharm Des 2010;16:3233–45.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Inhibition of bacterial carbonic anhydrases and zinc proteases: from orphan targets to innovative new antibiotic drugs. Curr Med Chem 2012;19:831–44.
   PubMed Web of Science ®Google Scholar
• Touisni N, Maresca A, McDonald PC, et al. Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors. J Med Chem 2011;54:8271–7.
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Menabuoni L, Mincione F, et al Carbonic anhydrase inhibitors. Synthesis of sulfonamides incorporating dtpa tails and of their zinc complexes with powerful topical antiglaucoma properties. Bioorg Med Chem Lett 2001;11:575–82.
   PubMed Web of Science ®Google Scholar
• Johnson CK, ORTEP-II. A Fortran thermal-ellipsoid plot program. Report ORNL-5318. Oak Ridge, TN: Oak Ridge National Laboratory; 1976
   Google Scholar
• Lin C-C, Hsieh T-H, Liao P-Y, et al Practical synthesis of N-substituted cyanamides via tiemann rearrangement of amidoximes. Org Lett 2014;16:892–5.
   PubMed Web of Science ®Google Scholar
• Prestch E, Clerc T, Seibl J, Simon W. Tablas para la dilucidación estructural de compuestos orgánicos por métodos espectroscópicos: ¹³CNMR, ¹H-NMR, IR, EM, UV-Vis. Barcelona: Singer Verlag-Ibérica; 1998.
   Google Scholar
• Koch U, Popelier PLA. Characterization of C-H-O hydrogen bonds on the basis of the charge density. J Phys Chem 1995;99:9747–54.
   Web of Science ®Google Scholar
• Supuran CT, Casini A, Mastrolorenzo A, Scozzafava A. COX-2 selective inhibitors, carbonic anhydrase inhibition and anticancer properties of sulfonamides belonging to this class of pharmacological agents. Mini Rev Med Chem 2004;4:625–32.
   PubMed Web of Science ®Google Scholar
• De Simone G, Di Fiore A, Supuran CT. Are carbonic anhydrase inhibitors suitable for obtaining antiobesity drugs? Curr Pharm Des 2008;14:655–60.
   PubMed Web of Science ®Google Scholar
• Supuran CT. How many carbonic anhydrase inhibition mechanisms exist? J Enzyme Inhib Med Chem 2016;31:345–60.
   PubMed Web of Science ®Google Scholar
• Capasso C, Supuran CT. An overview of the alpha-, beta- and gamma-carbonic anhydrases from bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria? J Enzyme Inhib Med Chem 2015;30:325–32.
   PubMed Web of Science ®Google Scholar
• Del Prete S, Vullo D, Fisher GM, et al. Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum - the η-carbonic anhydrases. Bioorg Med Chem Lett 2014;24:4389–96.
   PubMed Web of Science ®Google Scholar